Company & Sponsor Intelligence
University of Arkansas
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed1
Countries1
Therapeutic footprint
autismepilepsyparkinsons
Indexed studies
NCT02088047The Effects of ProFoveate on Reducing Self-Stimulating Behaviors
autism · United StatesNA
autism · United StatesNA
NCT04888637Pediatric Language and Memory Mapping in Refractory Epilepsy Using Magnetoencephalography
epilepsy · United StatesCOMPLETED
epilepsy · United StatesCOMPLETED
NCT00669461Lubiprostone as a Treatment for Constipation in Parkinson's Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →